DCN 179177

• CAT Number: I025615
• CAS Number: 73-80-3
• Molecular Formula: C19H26BrNO3S
• Molecular Weight: 428.39
• Purity: 98%
• Synonyms: DCN 179177; DCN-179177; DC179177
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (2-bromophenyl)methyl-diethyl-methylazanium;4-methylbenzenesulfonate
• InChI: InChI=1S/C12H19BrN.C7H8O3S/c1-4-14(3,5-2)10-11-8-6-7-9-12(11)13;1-6-2-4-7(5-3-6)11(8,9)10/h6-9H,4-5,10H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
• InChIKey: KGYGWDRZTMDSHS-UHFFFAOYSA-M
• SMILES: CC[N+](C)(CC)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]

DCN 179177（Cat No.:I025615）is an investigational small molecule compound being explored for its potential therapeutic applications in oncology and neurodegenerative diseases. It is designed to target specific molecular pathways involved in cancer cell proliferation, apoptosis, and metastasis. Preclinical studies suggest that DCN 179177 may inhibit tumor growth and help overcome drug resistance by interfering with critical cellular signaling mechanisms. Additionally, the compound may have neuroprotective effects, making it a candidate for conditions like Alzheimer’s and Parkinson’s disease. Further clinical trials are needed to evaluate its safety, efficacy, and therapeutic potential.